Ovarian cancer trials in Germany
45 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in GermanyUpdating the EORTC Quality-of-Life Questionnaire for Ovarian Cancer (QLQ-OV38)
- Where
- Wuppertal
- Age
- 18 years and over
- People
- 50
- Run by
- Helios University Hospital Wuppertal
See details and how to joinNCT07465133 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Hamburg, Heilbronn, Munich
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - Phase 1Taking peopleA Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
- Where
- Munich, Wuerzburg
- Age
- 18 years and over
- People
- 187 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07306559 · EU 2025-522913-45-00 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Dresden, Essen, Frankfurt, Ulm, Würzburg
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Berlin, Frankfurt am Main, Heidelberg
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - Phase 3Taking peopleAZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Where
- Berlin, Bonn, Detmold, Dresden, Duesseldorf, Essen, Frankfurt am Main, Hamburg, Hanover, Leipzig, Mannheim, Schwaebisch Hall, Stuttgart, Tuebingen, Ulm, Wiesbaden
- Age
- 18 years and over
- People
- 1,100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00 - Phase 2Taking peopleRelacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- Where
- Aachen, Berlin, Kempten
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Corcept Therapeutics
See details and how to joinNCT06906341 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Erlangen
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - Phase 2Taking peopleA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Velbert
- Age
- 18 years and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - No phaseTaking peoplePerformance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
- Where
- Frankfurt am Main
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Aesculap AG
See details and how to joinNCT06024109 - Phase 1/2Taking peopleACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Where
- Berlin, Bonn, Dresden, Hamburg, Heidelberg, Mainz, Munich, Würzburg
- Age
- 18 years and over
- People
- 375 worldwide
- Run by
- Immatics US, Inc.
See details and how to joinNCT03686124 - Phase 1Taking peopleA first-in-human clinical study to assess safety and tolerability of genetically modified T-cells in ROR1 positive tumors
- Where
- Berlin, Cologne, Wuerzburg
- Age
- 18 years and over
- People
- 44
- Run by
- Universitaetsklinikum Wuerzburg AöR
See details and how to join2024-512019-36-00 - No phaseTaking peopleTUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- Where
- Amberg, Berlin-Spandau, Detmold, Essen
- Age
- 25 years to 50 years
- People
- 3,000 worldwide
- Run by
- University Medical Center Nijmegen
See details and how to joinNCT04294927 - No phaseTaking peopleImmunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
- Where
- Tübingen
- Age
- 18 years and over
- People
- 120
- Run by
- University Hospital Tuebingen
See details and how to joinNCT05914974 - No phaseTaking peopleRegistry Platform Ovarian and Endometrial Cancer
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 1,975
- Run by
- iOMEDICO AG
See details and how to joinNCT05129969 - Phase 2Taking peopleCATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Where
- Berlin, Erlangen, Hamburg, Heidelberg, Mannheim, Tuebingen
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- TORL Biotherapeutics, LLC
See details and how to joinNCT06690775 · EU 2024-517190-24-00 - Phase 3Taking peopleMAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
- Where
- Berlin, Cologne, Deggendorf, Dresden, Duesseldorf, Essen, Esslingen am Neckar, Freiburg im Breisgau, Hamburg, Hildesheim, Konstanz, Mainz, Mannheim, Muenster, Munich, Ravensburg, Rosenheim, Schweinfurt, Ulm, Wiesbaden, Wolfsburg, Wuppertal
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Swiss GO Trial Group
See details and how to joinNCT04111978 · EU 2024-511219-78-00 - Phase 3Taking peopleNiraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
- Where
- Amberg, Augsburg, Bad Homburg, Berlin, Bielefeld, Brandenburg An Der Havel, Bremen, Chemnitz, Cologne, Dortmund, Dresden, Duesseldorf, Essen, Esslingen am Neckar, Frankfurt Am Main, Freiburg im Breisgau, Fulda, Gera, Giessen, Guetersloh, Halle Saale, Hamburg, Hanau, Hanover, Heidelberg, Heilbronn, Hildesheim, Jena, Karlsruhe, Kassel, Kempten (Allgau), Kiel, Konstanz, Krefeld, Leipzig, Limburg, Ludwigsburg, Luebeck, Magdeburg, Mainz, Mannheim, Marburg, Minden, Muenster, Munich, Neumarkt, Nordhausen, Offenburg, Paderborn, Ravensburg, Regensburg, Reutlingen, Rosenheim, Rostock, Saalfeld/Saale, Schweinfurt, Stralsund, Stuttgart, Traunstein, Trier, Tuebingen, Ulm, Wiesbaden, Worms
- Age
- 18 years and over
- People
- 970 worldwide
- Run by
- AGO Study Group
See details and how to joinNCT05009082 · EU 2024-516066-11-00 - No phaseTaking peopleEstablishment of a Tumor Bank for Blood Samples
- Where
- Berlin, Freiburg im Breisgau, Herne
- Age
- 18 years and over
- People
- 10,000 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT01763125 - No phaseTaking peopleEstablishment of a Tumor Bank for Tissue Samples
- Where
- Berlin
- Age
- 18 years and over
- People
- 10,000 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT01789229